Cardinal Health Inc. (NYSE:CAH) finished Friday with a subtraction of -$0.98 to close at $86.82, a downside of -1.12 percent. An average of 1,716,060 shares of common stock have been traded in the last five days. There was a fall of -$2.14 in the past week, and it reached a new high 35 times over the past 12 months. The last 20 days have seen an average of 1,893,210 shares traded, while the 50-day average volume stands at 2,176,492.
CAH stock has decreased by -1.39% in the last month. The company shares reached their 1-month lowest point of $86.56 on 09/05/23. With the stock rallying to its 52-week high on 08/15/23, shares of the company touched a low of $66.05 and a high of $95.45 in 52 weeks. It has reached a new high 29 times so far this year and achieved 12.94% or $9.95 in price. In spite of this, the price is down -9.04% from the 52-week high.
Insider Transactions
CAH stock investors should be aware that Cardinal Health Inc. (CAH) stock had its last reported insider trading activity 33 days ago on Aug 28. In this transaction, the insider spent $602,805. Chief Accounting Officer, Scherer Mary C., disposed of 20,695 shares at a price of $86.27 on Aug 18. The insider now owns more than $1,785,358 worth of shares. Prior to that, CEO, Medical Segment Mason Stephen M went on to Sale 37,500 shares at $87.32 each on Aug 17. An amount of $3,274,642 was transacted.
Valuation Metrics
Cardinal Health Inc. (CAH) has a trailing price-to-earnings (P/E) ratio of 87.69. The stock’s beta is 0.79. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.11, and the price-to-cash flow ratio at 9.23.
Financial Health
The quick ratio of Cardinal Health Inc. for the three months ended June 29 was 0.53, and the current ratio was 1.00, indicating that the company is not able to meet its debt obligations. Its gross profit as reported stood at $6.89 billion compared to revenue of $205.01 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Cardinal Health Inc.’s return on assets was 0.60%.
Earnings Surprise
For the three-month period that ended June 29, Cardinal Health Inc. had $3.91 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$64.0 million in the quarter, while revenues were grew 315.62%. The analyst consensus anticipated Cardinal Health Inc.’s latest quarter earnings to come in at $1.49 per share, but it turned out to be $1.55, a 4.00% surprise. For the quarter, EBITDA amounted to $313.0 million. Shareholders own equity worth $250.68 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Cardinal Health Inc. (CAH) price momentum. RSI 9-day as of the close on 29 September was 33.66%, suggesting the stock is Neutral, with historical volatility in this time frame at 10.65%.
As of today, CAH’s price is $88.11 -2.41% or -$2.14 from its 5-day moving average. CAH is currently trading -0.58% lower than its 20-day SMA and +3.17% higher than its 100-day SMA. However, the stock’s current price level is -7.74% below the SMA50 and +9.18% above the SMA200.
The stochastic %K and %D were 21.74% and 39.43%, respectively, and the average true range (ATR) was 1.24. With the 14-day stochastic at 3.13% and the average true range at 1.29, the RSI (14) stands at 39.42%. The stock has reached -0.92 on the 9-day MACD Oscillator while the 14-day reading was at -0.78.
Analyst Ratings
Evercore ISI downgraded Cardinal Health Inc. (NYSE: CAH) to a an In-line rating in its most recent analyst report. Previously, the stock was rated as an Outperform. The consensus rating for Cardinal Health Inc. (CAH) among analysts is Hold. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CAH, while 10 suggest investors hold. There are 1 analyst who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 3 others rate it as a “buy”.
